ISSN: 0443-511
e-ISSN: 2448-5667
Usuario/a
Idioma
Herramientas del artículo
Envíe este artículo por correo electrónico (Inicie sesión)
Enviar un correo electrónico al autor/a (Inicie sesión)
Tamaño de fuente

Open Journal Systems

Implementación de PCR isotérmica para detección de virus SARS-CoV-2 / Implementation of isotermic PCR for detection of SARS-CoV-2 virus

Esmeralda Campos-Aguirre, Nelly Davila-Estrella, Gamaliel Benitez-Arvizu

Resumen


 

Resumen

Durante la pandemia por SARS-CoV-2 se implementaron medidas para disminuir el contagio en hospitales. Entre esas medidas se incluyeron pruebas de RT-PCR (reacción en cadena polimerasa por transcriptasa reversa), con tiempo estimado de entrega del resultado de aproximadamente 3 horas. El ensayo Abbott ID NOW™ COVID-19 (Abbott Laboratories Chicago, IL) se hace en un dispositivo portátil por tecnología isotérmica para amplificación de ácidos nucleicos y puede producir un resultado cualitativo en 13 minutos. La finalidad de este artículo es determinar si la concordancia de la PCR isotérmica con la RT-PCR es buena para su implementación en donantes de células troncales hematopoyéticas (CTH). Para realizarlo primero se determinó la concordancia de la PCR isotérmica con RT-PCR utilizando muestras con resultado tanto positivo como negativo a este último método. Después se dio seguimiento en el programa de trasplante y se utilizó la PCR isotérmica para detección de COVID-19 en donadores de CTH previo a la recolección. Se compararon las opiniones entre otros estudios y lo observado en nuestra unidad hospitalaria y contrastó en primer lugar la concordancia encontrada (0.949) y en segundo lugar la experiencia con la implementación de la PCR isotérmica como método de detección, con lo cual concluimos que el ensayo Abbott ID NOWTM COVID-19 es concordante con la RT-PCR convencional para la detección de SARS-CoV-2 y es útil cuando se requiere reducir el tiempo de respuesta.

 

Abstract

During the SARS CoV-2 pandemic, measures were implemented to reduce contagion in hospitals. Among those measures it was included RT-PCR (reverse transcriptose polymerase chain reaction) tests, with an estimated result delivery time of approximately 3 hours. The Abbott ID NOW™ COVID-19 assay (Abbott Laboratories Chicago, IL) is performed on a portable device using isothermal technology for nucleic acid amplification that can produce a qualitative result in 13 minutes. The purpose of this article was to determine if the concordance of isothermal PCR with RT-PCR is good for its implementation in hematopoietic stem cell (HSC) donors. To do this, the concordance of isothermal PCR with RT-PCR was determined using samples with both positive and negative results for the latter method. Follow-up was then carried out in the transplant program, using isothermal PCR to detect COVID-19 in HSC donors prior to collection. A comparison of opinions was made between other studies and what was observed in our hospital unit, contrasting firstly the concordance found (0.949) and secondly the experience with the implementation of isothermal PCR as a detection method, with which we conclude that the Abbott ID NOWTM COVID-19 assay is concordant with conventional RT-PCR for the detection of SARS-CoV-2, and it is useful when reducing response time is required.


Palabras clave


Prueba de COVID-19; Reacción en Cadena de la Polimerasa de Transcriptasa Inversa; Pruebas en el Punto de Atención / COVID-19 Testing; Reverse Transcriptase Polymerase Chain Reaction; Point-of-Care Testing

Texto completo:

PDF

Referencias


Knihs N da S, Paim SMS, Magalhães ALP, et al. Care actions in obtaining tissues and organs during the COVID-19 pandemic: a mixed methods study. Rev Bras Enferm. 2022;75. doi: 10.1590/0034-7167-2021-0613.

Segura-Ulate I, Bolívar-González A, Madrigal-Redondo G, et al. Reverse-Transcription Loop-Mediated Isothermal Amplification and alternative protocols for lower cost, large-scale COVID-19 testing: lessons from an emerging economy. Rev Biol Trop. 2022;70(1):173-89. doi: 10.15517/rev.biol.trop..v70i1.47407.

Wölfel R, Corman VM, Guggemos W, et al. Virological assessment of hospitalized patients with COVID-2019. Nature. 2020;581(7809):465-9. doi: 10.1038/s41586-020-2196-x.

Mercer TR, Salit M. Testing at scale during the COVID-19 pandemic. Nat Rev Genet. 2021;22(7):415-26. doi: 10.1038/s41576-021-00360-w

Ahmadzadeh M, Vahidi H, Mahboubi A, et al. Different Respiratory Samples for COVID-19 Detection by Standard and Direct Quantitative RT-PCR: A Literature Review. Iranian Journal of Pharmaceutical Research. 2021;20(3):285-99. doi: 10.22037/IJPR.2021.115458.15383.

Carter LJ, Garner LV, Smoot JW, et al. Assay Techniques and Test Development for COVID-19 Diagnosis. ACS Cent Sci. 2020;6(5):591-605. doi: 10.1021/acscentsci.0c00501.

Ganguli A, Mostafa A, Berger J, et al. Rapid isothermal amplification and portable detection system for SARS-CoV-2. Proc Natl Acad Sci U S A. 2020;117(37):22727-22735. doi: 10.1073/pnas.2014739117.

De Felice M, De Falco M, Zappi D, et al. Isothermal amplification-assisted diagnostics for COVID-19. Biosens Bioelectron. 2022;205. doi: 10.1016/j.bios.2022.114101.

Chaouch M. Loop-mediated isothermal amplification (LAMP): An effective molecular point-of-care technique for the rapid diagnosis of coronavirus SARS-CoV-2. Rev Med Virol. 2021;31(6). doi: 10.1002/rmv.2215.

More N, Ranglani D, Kharche S, et al. Current challenges in identification of clinical characteristics and detection of COVID-19: A comprehensive review. Measurement: Sensors. 2021;16. doi: 10.1016/j.measen.2021.100052.

Fan SL. Application of Abbott ID NOW in the emergency department for SARS-CoV-2 detection: A medical center’s perspective. Clin Biochem. 2023;117:30-3. doi: 10.1016/j.clinbiochem.2022.04.007.

Tu YP, Iqbal J, O’leary T. Sensitivity of id now and rt–pcr for detection of sars-cov-2 in an ambulatory population. Elife. 2021;10:e65726. doi: 10.7554/ELIFE.65726.

Barker KR, Small LN, Thai DV, et al. Evaluating the Ability to ID (COVID-19) NOW: a Large Real-World Prospective Evaluation of the Abbott ID NOW COVID-19 Assay. Microbiol Spectr. 2022;10(3):e00513-22. doi: 10.1128/spectrum.00513-22.

Pattnaik D, Poddar N, Pathi BK, et al. Comparative Evaluation of Cartridge-Based Abbott ID NOW Test With Probe-Based Real-Time Reverse Transcription Polymerase Chain Reaction Assay for Detection of SARS-CoV-2. Cureus. 2022;14(2). doi: 10.7759/cureus.22470.

LeBlanc JJ, McCracken GR, Goodall B, et al. Avoiding false positive SARS-CoV-2 rapid antigen test results with point-of-care molecular testing on residual test buffer. Microbiol Spectr. 2022;10(4):e0063922. doi: 10.1128/spectrum.00639-22.

Barnacle JR, Houston H, Baltas I, et al. Diagnostic accuracy of the Abbott ID NOW SARS-CoV-2 rapid test for the triage of acute medical admissions. Journal of Hospital Infection. 2022;123:92-99. doi: 10.1016/j.jhin.2022.02.010.

Srivastava S, Singh P, Malhotra R, et al. Comparison of Abbott ID NOW, a novel isothermal amplification based COVID-19 diagnostic method with RTPCR. J Virol Methods. 2022;304. doi: 10.1016/j.jviromet.2022.114521.

COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health. Disponible en: https://www.covid19treatmentguidelines.nih.gov/

Lee J, Song JU. Diagnostic accuracy of the Cepheid Xpert Xpress and the Abbott ID NOW assay for rapid detection of SARS-CoV-2: A systematic review and meta-analysis. J Med Virol. 2021;93(7):4523-31. doi: 10.1002/jmv.26994.

Mahmoud SA, Ganesan S, Ibrahim E, et al. Evaluation of six different rapid methods for nucleic acid detection of SARS-COV-2 virus. J Med Virol. 2021;93(9):5538-43. doi: 10.1002/jmv.27090.

Subsoontorn P, Lohitnavy M, Kongkaew C. The diagnostic accuracy of isothermal nucleic acid point-of-care tests for human coronaviruses: A systematic review and meta-analysis. Sci Rep. 2020;10(1). doi: 10.1038/s41598-020-79237-7.

Lee CC, Lee YT, Wang CH, et al. Guidelines for COVID-19 Laboratory Testing for Emergency Departments From the New Diagnostic Technology Team of the Taiwan Society of Emergency Medicine. J Acute Med. 2022;12(2):45-52. doi: 10.6705/j.jacme.202206_12(2).0001.

Zhao Z, Li R, Ma Y, et al. Supporting Technologies for COVID-19 Prevention: Systemized Review. JMIRx Med. 2022;3(2):e30344. doi: 10.2196/30344.

Stokes W, Venner AA, Buss E, et al. Then and NOW: A Prospective Population-Level Validation of the Abbott ID NOW SARS-CoV-2 Device 2 Implemented in Multiple Settings for Testing 3 Asymptomatic and Symptomatic Individuals 4 5. MedRxiv. 2022;4(30):2227418. doi: 10.1101/2022.04.30.22274189.

He W, Yi GY, Zhu Y. Estimation of the basic reproduction number, average incubation time, asymptomatic infection rate, and case fatality rate for COVID-19: Meta-analysis and sensitivity analysis. J Med Virol. 2020;92(11):2543-50. doi: 10.1002/jmv.26041.

Zhang M, Zhou H, Truant AL. Problematic Specimens in an Academic Clinical Microbiology Laboratory: A Pilot Quality Assurance Study. American Society for Clinical Pathology. 2013;10(2):140-60. Disponible en: https://academic.oup.com/ajcp/article/140/suppl_1/A160/1771573.

Shinozawa S, Moriyama Y. Three SARS-CoV-2 PCR-negative cases of COVID-19 diagnosed using isothermal amplification methods. Journal of Infection and Chemotherapy. 2022;28(7):1005-7. doi: 10.1016/j.jiac.2022.04.002.

Babic N, Garner KS, Hirschhorn JW, et al. Evaluation of Abbott ID NOW COVID-19 POC test performance characteristics and integration in the regional health network workflows to improve health care delivery. Clin Biochem. 2023;117:69-73. doi: 10.1016/j.clinbiochem.2021.12.003.




DOI: https://doi.org/10.24875/10.5281/zenodo.10998931

Enlaces refback

  • No hay ningún enlace refback.